a b s t r a c t
This study investigated the neurobiological basis of attentional control dysfunction in neurodegenerative disease by determining the effect of regional brain atrophy on Flanker task performance of neurodegenerative patients. We hypothesized that atrophy in DLPFC and ACC would be significantly associated with decreased attentional control performance on the Flanker task. We used voxel-based morphometry (VBM) to measure the relationship between MRI measures of regional grey matter atrophy and performance on a version of the Flanker task, measured by accuracy and response time. Sixty-five subjects participated, including patients with frontotemporal dementia, Alzheimer's disease, mild cognitive impairment, non-fluent progressive aphasia, corticobasal degeneration, progressive supranuclear palsy, semantic dementia, and healthy controls. Accuracy measures of attentional control and response time measures of attentional control were associated with two different patterns of regional atrophy across subjects. First, there was an association between left hemisphere DLPFC and ACC atrophy and poorer attentional control accuracy. Second, right hemisphere temporal-parietal junction (TPJ) and ventrolateral prefrontal cortex (VLPFC) and DLPFC atrophy were associated with slower response times during attentional control on accurate trials, which may reflect emergent involvement due to deficits in the DLPFC-ACC network.
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Introduction
Clinical descriptions and empirical studies of patients with neurodegenerative disease have highlighted the presence of "executive function" symptoms such as confusion, distractibility, poor planning, and deficits in carrying out goal-directed behavior (Miller & Cummings, 2007) . Measures of executive function are the best predictor of a patient's score on Indices of Daily Living, which measure how well patients are able to maintain quality of life during disease progression (Cahn-Weiner et al., 2007) . Executive deficits can underlie memory and learning dysfunction (Matuszewski et al., 2006; Wicklund, Johnson, Rademaker, Weitner, & Weintraub, 2006) , and are associated with lack of disease insight and difficult patient-caregiver relationships.
One important executive function is attentional control. Attentional control is the goal-driven allocation of attention toward the processing of task-appropriate stimuli and responses, particularly when we experience competition, or "conflict", between the processing of task-relevant information and items that distract us. Effective attentional control is dependent upon self-monitoring mechanisms to determine whether behavioral goals are met, or whether additional efforts are required. While many of the abnormal social and cognitive behaviors observed in neurodegenerative patients may result from progressive deficits of attentional control, the neurobiological bases for these attention dysfunctions in neurodegenerative disease are largely unknown.
In the healthy brain, there is evidence that attentional control processes are mediated by a large-scale network involving frontal and parietal systems that interact with sensory and motor areas (e.g. Banich et al., 2000; Mesulam, 1981; Miller & Cohen, 2001; Posner & Petersen, 1990 ). This network is particularly engaged in situations in which goal-relevant response selection is made difficult by competition from other responses (Paus, Koski, Caramanos, & Westbury, 1998; Rafal et al., 1996) . This competition can arise because one response is task relevant, but the other has stronger
